Inspiron in bronchopulmonary pathologies of viral-bacterial etiology in children

Abstract

100 children from 2 to 10 years of age including with bronchopulmonary pathology of viral-bacterial etiology were examined for the purpose of studying the clinical efficacy and safety of the use of Inspiron. The main group of 50 children received Inspiron, control (50 people) – ambroxol. The efficacy and safety of the drug was assessed by the dynamics of bronchial obstructive syndrome, cough, dyspnea, physical parameters of the respiratory system, tolerabil-ity and the presence of allergic reactions. The carried out researches have shown high efficiency of the preparation «Inspiron». A pronounced broncho-obstructive, mucolytic, antitussive effect was revealed, and an easier withdrawal of sputum was recorded. In no case are allergic reactions or laryngospasm recorded. There was a significant reduction in the stay of children in the hospi-tal, which led to a reduction in the costs of the medical institution for treatment and examination.